生存期-话题@MedSci

#生存期#

350篇内容 | 3612人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1378129, encodeId=04df13e8129e5, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Ann Oncol：早期手术切除可延长渗透性低级胶质瘤的生存期！, objectType=article, longId=98191, objectId=167f9819169, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=167f9819169, replyNumber=0, likeNumber=64, createdTime=2017-05-10, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=167f9819169, moduleTitle=Ann Oncol：早期手术切除可延长渗透性低级胶质瘤的生存期！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=167f9819169)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378128, encodeId=49b913e812894, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Leuk Lymphoma：AML青少年和年轻人生存期存在种族差异, objectType=article, longId=97780, objectId=ab689e78048, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab689e78048, replyNumber=0, likeNumber=71, createdTime=2017-05-04, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab689e78048, moduleTitle=Leuk Lymphoma：AML青少年和年轻人生存期存在种族差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab689e78048)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378127, encodeId=7b0e13e812749, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=J UROLOGY：二甲双胍不能增加前列腺癌的生存期, objectType=article, longId=95631, objectId=c7909563118, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7909563118, replyNumber=0, likeNumber=74, createdTime=2017-04-14, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7909563118, moduleTitle=J UROLOGY：二甲双胍不能增加前列腺癌的生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7909563118)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378126, encodeId=9a4313e8126a6, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=重磅！阿斯利康药物奥拉帕尼在卵巢癌3期临床试验中显著延长生存期, objectType=article, longId=92752, objectId=b15992e526b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b15992e526b, replyNumber=0, likeNumber=76, createdTime=2017-03-23, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b15992e526b, moduleTitle=重磅！阿斯利康药物奥拉帕尼在卵巢癌3期临床试验中显著延长生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b15992e526b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378125, encodeId=10ac13e81255c, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=中山大学发现肝癌治疗新手段帮助患者延长生存期, objectType=article, longId=92537, objectId=1bb29253e48, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1bb29253e48, replyNumber=0, likeNumber=96, createdTime=2017-03-21, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1bb29253e48, moduleTitle=中山大学发现肝癌治疗新手段帮助患者延长生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1bb29253e48)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378124, encodeId=1a2613e8124e4, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Intens Care Med：中重度迟发型ARDS与更短的生存期和更高的死亡率相关！, objectType=article, longId=92016, objectId=d0e392016be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d0e392016be, replyNumber=0, likeNumber=25, createdTime=2017-03-17, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d0e392016be, moduleTitle=Intens Care Med：中重度迟发型ARDS与更短的生存期和更高的死亡率相关！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d0e392016be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378123, encodeId=209a13e8123bc, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=多数肺移植受者实现2年生存期获益, objectType=article, longId=91219, objectId=007791219ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=007791219ee, replyNumber=0, likeNumber=66, createdTime=2017-03-10, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=007791219ee, moduleTitle=多数肺移植受者实现2年生存期获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=007791219ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378122, encodeId=407c13e812264, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=JAMA吐槽“高价无效”抗癌药：18种药均未延长生存期, objectType=article, longId=83907, objectId=e8fe8390e1f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8fe8390e1f, replyNumber=0, likeNumber=84, createdTime=2016-12-11, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8fe8390e1f, moduleTitle=JAMA吐槽“高价无效”抗癌药：18种药均未延长生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e8fe8390e1f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378121, encodeId=134b13e812136, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=JAMA：吐槽“高价无效”抗癌药，18种药均未延长生存期, objectType=article, longId=83792, objectId=721283e92b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=721283e92b0, replyNumber=0, likeNumber=78, createdTime=2016-12-10, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=721283e92b0, moduleTitle=JAMA：吐槽“高价无效”抗癌药，18种药均未延长生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=721283e92b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378120, encodeId=255713e812075, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=NEJM：Palbociclib+来曲唑治疗可显著延长晚期乳腺癌患者的无进展生存期, objectType=article, longId=82539, objectId=ade982539bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ade982539bd, replyNumber=0, likeNumber=108, createdTime=2016-11-18, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ade982539bd, moduleTitle=NEJM：Palbociclib+来曲唑治疗可显著延长晚期乳腺癌患者的无进展生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ade982539bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378119, encodeId=ee2413e8119b3, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=JAMA Surg：胆囊癌患者再次手术的时机影响患者生存期, objectType=article, longId=81681, objectId=00908168183, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=00908168183, replyNumber=0, likeNumber=65, createdTime=2016-11-04, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=00908168183, moduleTitle=JAMA Surg：胆囊癌患者再次手术的时机影响患者生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=00908168183)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378118, encodeId=651113e811878, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Br J Cancer：疾病进展时间和肝癌总生存期有什么联系？, objectType=article, longId=80609, objectId=15f480609e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=15f480609e8, replyNumber=0, likeNumber=73, createdTime=2016-10-22, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=15f480609e8, moduleTitle=Br J Cancer：疾病进展时间和肝癌总生存期有什么联系？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=15f480609e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378117, encodeId=d7ab13e811786, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=试验表明索坦辅助治疗可延长肾细胞癌患者术后无病生存期, objectType=article, longId=80552, objectId=62f380552e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62f380552e9, replyNumber=0, likeNumber=78, createdTime=2016-10-22, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62f380552e9, moduleTitle=试验表明索坦辅助治疗可延长肾细胞癌患者术后无病生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62f380552e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378116, encodeId=b1bc13e8116d6, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=NEJM：舒尼替尼可显著延长高危肾细胞癌患者肾切除术后的无病生存期, objectType=article, longId=79759, objectId=ccaae97590a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ccaae97590a, replyNumber=0, likeNumber=75, createdTime=2016-10-12, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ccaae97590a, moduleTitle=NEJM：舒尼替尼可显著延长高危肾细胞癌患者肾切除术后的无病生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ccaae97590a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378115, encodeId=00cf13e811533, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=NEJM：Nivolumab可延长复发性头颈鳞状细胞癌患者的总生存期, objectType=article, longId=79706, objectId=03fbe9706d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=03fbe9706d9, replyNumber=0, likeNumber=78, createdTime=2016-10-12, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=03fbe9706d9, moduleTitle=NEJM：Nivolumab可延长复发性头颈鳞状细胞癌患者的总生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=03fbe9706d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378114, encodeId=66d513e811476, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=ESMO 2016：新辅助放化疗可延长局部晚期食管鳞状细胞癌患者的生存期, objectType=article, longId=79647, objectId=cd0be96471b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd0be96471b, replyNumber=0, likeNumber=33, createdTime=2016-10-11, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd0be96471b, moduleTitle=ESMO 2016：新辅助放化疗可延长局部晚期食管鳞状细胞癌患者的生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd0be96471b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378113, encodeId=8cbd13e811383, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=ESMO 2016：奥拉帕尼能否改善胃癌患者的总生存期？（GOLD试验）, objectType=article, longId=79623, objectId=aa97e962349, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa97e962349, replyNumber=0, likeNumber=79, createdTime=2016-10-11, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa97e962349, moduleTitle=ESMO 2016：奥拉帕尼能否改善胃癌患者的总生存期？（GOLD试验）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aa97e962349)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378112, encodeId=dc0b13e8112aa, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=ESMO 2016：氟维司群可延长乳腺癌患者的无进展生存期（FALCON试验）, objectType=article, longId=79621, objectId=d717e96216e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d717e96216e, replyNumber=0, likeNumber=81, createdTime=2016-10-11, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d717e96216e, moduleTitle=ESMO 2016：氟维司群可延长乳腺癌患者的无进展生存期（FALCON试验）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d717e96216e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378111, encodeId=597f13e8111a8, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=NEJM：Niraparib可显著延长铂敏感的复发性卵巢癌患者无进展生存期, objectType=article, longId=79605, objectId=925ae9605d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=925ae9605d0, replyNumber=0, likeNumber=90, createdTime=2016-10-10, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=925ae9605d0, moduleTitle=NEJM：Niraparib可显著延长铂敏感的复发性卵巢癌患者无进展生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=925ae9605d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378110, encodeId=909213e811062, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=NEJM：HR阳性HER2阴性的晚期乳腺癌，ribociclib联合来曲唑可明显延长患者的无进展生存期, objectType=article, longId=79604, objectId=a2e5e960448, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a2e5e960448, replyNumber=0, likeNumber=81, createdTime=2016-10-10, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a2e5e960448, moduleTitle=NEJM：HR阳性HER2阴性的晚期乳腺癌，ribociclib联合来曲唑可明显延长患者的无进展生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a2e5e960448)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

生存期

2020-05-29

仁心济世 (审核中...)

前往app查看评论内容

#生存期#

Ann Oncol：早期手术切除可延长渗透性低级胶质瘤的生存期！

2017-05-10

仁心济世 (审核中...)

前往app查看评论内容

#生存期#

Leuk Lymphoma：AML青少年和年轻人生存期存在种族差异

2017-05-04

仁心济世 (审核中...)

前往app查看评论内容

#生存期#

J UROLOGY：二甲双胍不能增加前列腺癌的生存期

2017-04-14

仁心济世 (审核中...)

前往app查看评论内容

#生存期#

重磅！阿斯利康药物奥拉帕尼在卵巢癌3期临床试验中显著延长生存期

2017-03-23

仁心济世 (审核中...)

前往app查看评论内容

#生存期#

中山大学发现肝癌治疗新手段帮助患者延长生存期

2017-03-21

仁心济世 (审核中...)

前往app查看评论内容

#生存期#

Intens Care Med：中重度迟发型ARDS与更短的生存期和更高的死亡率相关！

2017-03-17

仁心济世 (审核中...)

前往app查看评论内容

#生存期#

多数肺移植受者实现2年生存期获益

2017-03-10

仁心济世 (审核中...)

前往app查看评论内容

#生存期#

JAMA吐槽“高价无效”抗癌药：18种药均未延长生存期

2016-12-11

仁心济世 (审核中...)

前往app查看评论内容

#生存期#

JAMA：吐槽“高价无效”抗癌药，18种药均未延长生存期

2016-12-10

仁心济世 (审核中...)

前往app查看评论内容

#生存期#

NEJM：Palbociclib+来曲唑治疗可显著延长晚期乳腺癌患者的无进展生存期

2016-11-18

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

JAMA Surg：胆囊癌患者再次手术的时机影响患者生存期

2016-11-04

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

Br J Cancer：疾病进展时间和肝癌总生存期有什么联系？

2016-10-22

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

试验表明索坦辅助治疗可延长肾细胞癌患者术后无病生存期

2016-10-22

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

NEJM：舒尼替尼可显著延长高危肾细胞癌患者肾切除术后的无病生存期

2016-10-12

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

NEJM：Nivolumab可延长复发性头颈鳞状细胞癌患者的总生存期

2016-10-12

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

ESMO 2016：新辅助放化疗可延长局部晚期食管鳞状细胞癌患者的生存期

2016-10-11

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

ESMO 2016：奥拉帕尼能否改善胃癌患者的总生存期？（GOLD试验）

2016-10-11

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

ESMO 2016：氟维司群可延长乳腺癌患者的无进展生存期（FALCON试验）

2016-10-11

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

NEJM：Niraparib可显著延长铂敏感的复发性卵巢癌患者无进展生存期

2016-10-10

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

NEJM：HR阳性HER2阴性的晚期乳腺癌，ribociclib联合来曲唑可明显延长患者的无进展生存期

2016-10-10

科室
- - 订阅+
  - 更多科室
工具
服务